BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27733783)

  • 1. Minimum dose, antigen content, and immunization duration of a trivalent vaccine of inactivated
    Zhao Z; Liu H; Zhang K; Xue Q; Chen K; Xue Y
    Can J Vet Res; 2016 Oct; 80(4):287-293. PubMed ID: 27733783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of efficacy obtained with a trivalent inactivated
    Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C
    Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
    Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sow vaccination modulates the colonization of piglets by Haemophilus parasuis.
    Cerdà-Cuéllar M; Naranjo JF; Verge A; Nofrarías M; Cortey M; Olvera A; Segalés J; Aragon V
    Vet Microbiol; 2010 Oct; 145(3-4):315-20. PubMed ID: 20447775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
    Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
    Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field evaluation of the efficacy, compatibility and serologic profiling of a combined vaccine against porcine reproductive and respiratory syndrome and Haemophilus parasuis in nursery pigs.
    Palzer A; Eddicks M; Zoels S; Stark J; Reese S; Strutzberg-Minder K; Fiebig K; Ritzmann M
    Prev Vet Med; 2015 May; 119(3-4):134-40. PubMed ID: 25819628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-protection experiment in pigs vaccinated with Haemophilus parasuis serovars 2 and 5 bacterins, and evaluation of a bivalent vaccine under laboratory and field conditions.
    Takahashi K; Naga S; Yagihashi T; Ikehata T; Nakano Y; Senna K; Maruyama T; Murofushi J
    J Vet Med Sci; 2001 May; 63(5):487-91. PubMed ID: 11411491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
    Li M; Li C; Song S; Kang H; Yang D; Li G
    Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a homologous bacterin given to sows prefarrowing on the development of Glässer's disease in postweaning pigs after i.v. challenge with Haemophilus parasuis serotype 5.
    Hoffmann CR; Bilkei G
    Dtsch Tierarztl Wochenschr; 2002 Jun; 109(6):271-6. PubMed ID: 12125173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.
    Hu M; Zhang Y; Xie F; Li G; Li J; Si W; Liu S; Hu S; Zhang Z; Shen N; Wang C
    Clin Vaccine Immunol; 2013 Jun; 20(6):795-802. PubMed ID: 23536691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to oligopeptide permease A (OppA) protein in pigs naturally and experimentally infected with Haemophilus parasuis.
    Macedo N; Oliveira S; Torremorell M; Rovira A
    Res Vet Sci; 2016 Aug; 107():62-67. PubMed ID: 27473976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cross-reaction among virulence-associated trimeric autotransporters (VtaA) of Haemophilus parasuis.
    Olvera A; Martínez-Moliner V; Pina-Pedrero S; Pérez-Simó M; Galofré-Milà N; Costa-Hurtado M; Aragon V; Bensaid A
    Vet Microbiol; 2013 Jun; 164(3-4):387-91. PubMed ID: 23510658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
    Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
    BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).
    Olvera A; Pina S; Pérez-Simó M; Aragón V; Segalés J; Bensaid A
    Vaccine; 2011 Mar; 29(15):2797-802. PubMed ID: 21320547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus parasuis vaccines.
    Liu H; Xue Q; Zeng Q; Zhao Z
    Vet Immunol Immunopathol; 2016 Nov; 180():53-58. PubMed ID: 27692096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets.
    Li XH; Zhao GZ; Qiu LX; Dai AL; Wu WW; Yang XY
    Biomed Res Int; 2015; 2015():649878. PubMed ID: 26688815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic profiling of Haemophilus parasuis-vaccinated sows and their litters using a novel oligopeptide permease A enzyme-linked immunosorbent assay reveals unexpected patterns of serological response and maternal antibody transfer.
    Galina Pantoja L; Stammen B; Minton B; Amodie D
    J Vet Diagn Invest; 2014 Jan; 26(1):125-30. PubMed ID: 24407228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TbpB
    Dellagostin D; Klein RL; Giacobbo I; Guizzo JA; Dazzi CC; Prigol SR; Martín CBG; Kreutz LC; Schryvers AB; Frandoloso R
    Vet Microbiol; 2023 Jan; 276():109630. PubMed ID: 36525718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
    Hau SJ; Eberle KC; Brockmeier SL
    Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
    Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.